Benefits of 18F-FET PET in preoperative assessment of glioma heterogeneity demonstrated in two case reports
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F21%3A00078861" target="_blank" >RIV/00209805:_____/21:00078861 - isvavai.cz</a>
Result on the web
<a href="https://www.csnn.eu/en/journals/czech-and-slovak-neurology-and-neurosurgery/2021-4-9/benefits-of-18f-fet-pet-in-preoperative-assessment-of-glioma-heterogeneity-demonstrated-in-two-case-reports-128182" target="_blank" >https://www.csnn.eu/en/journals/czech-and-slovak-neurology-and-neurosurgery/2021-4-9/benefits-of-18f-fet-pet-in-preoperative-assessment-of-glioma-heterogeneity-demonstrated-in-two-case-reports-128182</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.48095/cccsnn2021405" target="_blank" >10.48095/cccsnn2021405</a>
Alternative languages
Result language
angličtina
Original language name
Benefits of 18F-FET PET in preoperative assessment of glioma heterogeneity demonstrated in two case reports
Original language description
Magnetic resonance imaging is still considered the gold standard of dia gnostic algorithms in gliomas. However, especially in gliomas with atypical enhancement patterns, PET could improve evaluation by monitoring processes such as cell proliferation, membrane bio synthesis, and glucose consumption [1]. Radiolabeled amino acids are frequently used PET tracers due to their high signal-to-noise ratio. In contrast to glucose derivatives, the uptake of amino acids in infl ammatory cells is lower, which makes them more specific for tumor detection [2]. Moreover, amino acids are accumulated in malignant cells owing to increased expression of type L amino acid transporters in tumor vasculature [3]. Additionally, the counter-transport system A is overexpressed in neoplastic cells and seems to correlate positively with tumor cell growth rate [4]. Elevated transport of amino acids is a result of increased protein synthesis and also refl ects the increased demand by tumor cell metabolism [5]. Currently, [18F]-fl uoro-ethyl-L-tyrosine (18F-FET) is a promising amino acid radiotracer in dia gnosing low-grade glioma and its possible hot spots. Besides diff usion through the impaired blood-brain barrier (BBB), 18F-FET can additionally cross the BBB via endothelial L-transporters [6]. It also retains a relatively long half-life of 109 min. 18F-FET can be produced in large amounts for clinical purposes and is applicable in a satellite concept. In contrast, 3'-deoxy-3'-18F-fl uorothymidine (18F-FLT) is a radiolabeled analog of the DNA nucleoside that enters cells by active transport through nucleoside transporters and by passive diff usion [7]. As it does not cross the intact BBB [8] and refl ects tissue proliferation rate [9], the dia gnostic yield of 18F-FLT in low-grade gliomas (LGG) is questionable because of their more indolent bio logical course.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Československá neurologie a neurochirurgie
ISSN
0301-0597
e-ISSN
—
Volume of the periodical
84
Issue of the periodical within the volume
4
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
5
Pages from-to
405-409
UT code for WoS article
000738908000015
EID of the result in the Scopus database
—